argenx SE reported $493M in Operating Profit for its fiscal quarter ending in June of 2026.





Operating Profit Change Date
AstraZeneca USD 3.16B 3.95B Jun/2026
Genmab DKK 260M 199M Dec/2025
GlaxoSmithKline GBP 2.6B 312M Jun/2026
GRIFOLS EUR 329M 80M Jun/2026
Hikma Pharmaceutical USD 348M 161M Dec/2025
Lakefront Biotherapeutics EUR -63.7M 844.26M Mar/2026
Qiagen NV USD 116.63M 5.25M Mar/2026
UCB EUR 1.29B 571M Dec/2025